1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Primary Forms 1.2.3 Secondary Forms 1.3 Market by Application 1.3.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Research Institutes 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Perspective (2015-2026) 2.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Growth Trends by Regions 2.2.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Market Size 3.1.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Revenue (2015-2020) 3.1.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Players (2015-2020) 3.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue 3.4 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio 3.4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2019 3.5 Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Area Served 3.6 Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service 3.7 Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Breakdown Data by Type (2015-2026) 4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Type (2015-2020) 4.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Type (2021-2026) 5 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Breakdown Data by Application (2015-2026) 5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Application (2015-2020) 5.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2026) 6.2 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 6.3 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 6.4 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2026) 7.2 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 7.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 7.4 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2026) 8.2 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 8.3 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 8.4 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2026) 9.2 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 9.3 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 9.4 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2026) 10.2 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 10.3 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 10.4 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 11.1.4 Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)) 11.1.5 Pfizer Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 11.2.4 Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 11.2.5 Novartis Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 11.3.4 AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 11.3.5 AstraZeneca Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 11.4.4 Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 11.4.5 Merck Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 11.5.4 Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 11.5.5 Sanofi Recent Development 11.6 Daiichi Sankyo 11.6.1 Daiichi Sankyo Company Details 11.6.2 Daiichi Sankyo Business Overview 11.6.3 Daiichi Sankyo Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 11.6.4 Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 11.6.5 Daiichi Sankyo Recent Development 11.7 Bayer 11.7.1 Bayer Company Details 11.7.2 Bayer Business Overview 11.7.3 Bayer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 11.7.4 Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 11.7.5 Bayer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Primary Forms Table 4. Key Players of Secondary Forms Table 5. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2015-2020) Table 9. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2021-2026) Table 11. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Market Trends Table 12. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Drivers Table 13. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Challenges Table 14. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Restraints Table 15. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue by Players (2015-2020) (US$ Million) Table 16. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players (2015-2020) Table 17. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2019) Table 18. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (US$ Million) Table 23. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Type (2015-2020) Table 24. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2021-2026) Table 25. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2015-2020) Table 26. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (US$ Million) Table 27. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2021-2026) Table 28. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (US$ Million) Table 29. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 30. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (US$ Million) Table 31. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 32. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (US$ Million) (2015-2020) Table 33. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2015-2020) Table 34. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 36. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 38. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2015-2020) Table 40. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (US$ Million) Table 41. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 42. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (US$ Million) Table 43. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 44. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (US$ Million) (2015-2020) Table 45. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Region (2015-2020) Table 46. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 48. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 50. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2015-2020) Table 52. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 54. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 56. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2015-2020) Table 58. Pfizer Company Details Table 59. Pfizer Business Overview Table 60. Pfizer Product Table 61. Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (US$ Million) Table 62. Pfizer Recent Development Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Product Table 66. Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (US$ Million) Table 67. Novartis Recent Development Table 68. AstraZeneca Company Details Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Product Table 71. AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (US$ Million) Table 72. AstraZeneca Recent Development Table 73. Merck Company Details Table 74. Merck Business Overview Table 75. Merck Product Table 76. Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (US$ Million) Table 77. Merck Recent Development Table 78. Sanofi Company Details Table 79. Sanofi Business Overview Table 80. Sanofi Product Table 81. Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (US$ Million) Table 82. Sanofi Recent Development Table 83. Daiichi Sankyo Company Details Table 84. Daiichi Sankyo Business Overview Table 85. Daiichi Sankyo Product Table 86. Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (US$ Million) Table 87. Daiichi Sankyo Recent Development Table 88. Bayer Company Details Table 89. Bayer Business Overview Table 90. Bayer Product Table 91. Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (US$ Million) Table 92. Bayer Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type: 2020 VS 2026 Figure 2. Primary Forms Features Figure 3. Secondary Forms Features Figure 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Ambulatory Surgical Centers Case Studies Figure 8. Research Institutes Case Studies Figure 9. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Report Years Considered Figure 10. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (US$ Million), YoY Growth 2015-2026 Figure 11. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2021-2026) Figure 13. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players in 2019 Figure 14. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2019 Figure 16. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Canada Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Pfizer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 44. Novartis Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 45. AstraZeneca Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 46. Merck Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 47. Sanofi Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 48. Daiichi Sankyo Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 49. Bayer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Pfizer Novartis AstraZeneca Merck Sanofi Daiichi Sankyo Bayer